Investors cash in on KPower’s steady rise


KPower had planned to acquire a 70% stake in Granulab (M) Sdn Bhd, a unit of Sirim Bhd’s subsidiary, Sirim Tech Venture Sdn Bhd, for RM1mil cash

PETALING JAYA: KPower Bhd has experienced some trading interest in its shares following its plans to venture into the healthcare industry.

However, its shares ended lower after some profit-taking activities yesterday and declined to close 12 sen lower to RM7.60. The stock’s historical high was RM8.

It had planned to acquire a 70% stake in Granulab (M) Sdn Bhd, a unit of Sirim Bhd’s subsidiary, Sirim Tech Venture Sdn Bhd, for RM1mil cash.

Granulab is involved in the medical device manufacturing for granular synthetic bone graft “Granumas”, the only halal synthetic bone graft product in Malaysia, and producing medical devices and products.

KPower said the acquisition was in line with its intention to venture into the healthcare and technology business that can create long term revenue growth and income sustainability.

It had signed a US$6mil (RM24.05mil) agreement to supply polymerase chain reaction reagent kits for Covid-19 to PT Arna Cahaya Medika in Jakarta, Indonesia.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

KPower , Granulab , SIRIM Tech Venture , shares ,

   

Did you find this article insightful?

Yes
No

Next In Business News

CPO futures trading to remain range bound next week
Advisory panel unanimously recommends FDA authorize Johnson & Johnson COVID-19 vaccine
GameStop rally fizzles; shares still register 151% weekly gain
NYSE begins move to delist Chinese state oil producer CNOOC
Oil price drops on US$ strength and OPEC+ supply expectations
GLOBAL MARKETS-Globals stock slide on inflation fears
AMMB says it has enough capital to absorb 1MDB global settlement�
A five-year high for FGV Holdings
AMMB to pay RM2.83bil to the government
IHH to take proactive measures

Stories You'll Enjoy


Vouchers